NEU1 and pancreatic neoplasm: O’Shea’s team showed that oseltamivir inhibits the NEU-1 activity and suppresses the intrinsic signaling that promotes the cell survival of human pancreatic cancer (PANC1) cells that are resistant to drug therapy [51].